PUBLISHER: Grand View Research | PRODUCT CODE: 1511886
PUBLISHER: Grand View Research | PRODUCT CODE: 1511886
The global carbon dioxide incubators market size is expected to reach USD 1.1 billion, growing at a CAGR of 6.3% from 2024 to 2030, according to a new report by Grand View Research, Inc. CO2 incubators are utilized in several scientific and healthcare fields, offering controlled tissue and cell culture environments. They are essential for growth of tissues, cells, and microorganisms in laboratory settings. Moreover, emerging economies, characterized by expanding R&D activities, are experiencing a surge in demand for these advanced devices.
According to the South China Morning Post Publishers Ltd., China is the second-largest investor in R&D, with a total expenditure of USD 419 billion in 2022, which was 10.4% higher than in 2021. In addition, as these economies improve their healthcare infrastructure, the demand for in vitro fertilization and stem cell therapy grows, necessitating the use of CO2 incubators to ensure optimal conditions for cell growth. For instance, the Department of Biotechnology released funds worth USD 8.84 million till 2022 for stem cell, gene editing, and early & late translational research studies in India. The aforementioned effort from the regulatory authority is anticipated to boost the market in developing countries over the forecast period.
Technological advancements in Carbon Dioxide (CO2) incubators have revolutionized them, allowing more precise and controlled environments for cell culture, tissue engineering, & scientific research. These innovations have significantly enhanced experimental reproducibility, data integrity, and operational efficiency. One key advancement is the integration of advanced microprocessor-based control systems, which enable highly accurate regulation of temperature, humidity, & CO2 levels, minimizing fluctuations and providing researchers with consistent conditions for their experiments. This is particularly crucial in fields like stem cell research and drug discovery, where slight variations can impact results.
For instance, PHCbi's patented Direct Heat and Air Jacket incubators are equipped with advanced Infrared (IR) CO2 sensing technology, which utilizes a single beam with two detectors. This innovative approach ensures high stability and accuracy by concurrently measuring reference and sample wavelengths to facilitate continuous calibration. Integrating the sensor with a microprocessor controller ensures consistent performance unaffected by fluctuations in temperature and humidity. This technology operates on the principle of measuring the absorption of light by CO2 at a specific wavelength across a predetermined distance. Given that CO2 is the only compound that absorbs light at this wavelength, the sensor's functionality is independent of changes in temperature and humidity, ensuring reliable and precise operation.